1 Min Read
Jan 13 (Reuters) - Obalon Therapeutics Inc
* Obalon announces initial commercial patient placements of the first and only swallowable, FDA-approved balloon system for weight loss Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.